Growth factor-defined culture medium for human mesenchymal stem cells

International Journal of Developmental Biology

Volumn 55, Issue 2, 2011, Pages 181-187

  Mimura, Sumiyo ^a,b   Kimura, Naohiro ^b   Hirata, Mitsuhi ^a   Tateyama, Daiki ^a   Hayashida, Midori ^a   Umezawa, Akihiro ^c   Kohara, Arihiro ^a   Nikawa, Hiroki ^b   Okamoto, Tetsuji ^b   Furue, Miho K ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Mesenchymal stem cell; Serum free culture; TGF 1

Indexed keywords

CELL MARKER; ENDOGLIN; GROWTH FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; STEM CELL EXPANSION;

ANTIGENS, CD; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HOMEODOMAIN PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; RECEPTORS, CELL SURFACE; SOXB1 TRANSCRIPTION FACTORS; STAGE-SPECIFIC EMBRYONIC ANTIGENS; TISSUE CULTURE TECHNIQUES; TRANSFORMING GROWTH FACTOR BETA;

BOVINAE;

EID: 79958856453     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103232sm     Document Type: Article

References (34)

1. AMIT, M., SHARIKI, C., MARGULETS, V. and ITSKOVITZ-ELDOR, J. (2004). Feeder layer-and serum-free culture of human embryonic stem cells. Biol Reprod 70: 837-845.
2. BATTULA, V.L., TREML, S., ABELE, H. and BUHRING, H.J. (2008). Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation 76: 326-336.
3. BENAVENTE, C.A., SIERRALTA, W.D., CONGET, P.A. and MINGUELL, J.J. (2003). Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells. Growth Factors 21: 87-94.
4. BRUDER, S.P., JAISWAL, N. and HAYNESWORTH, S.E. (1997). Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64: 278-294.
5. CHASE, L.G., LAKSHMIPATHY, U., SOLCHAGA, L.A., RAO, M.S. and VEMURI, M.C. (2010). A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 1: 8.
6. COLTER, D.C., SEKIYA, I. and PROCKOP, D.J. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 98: 7841-7845.
7. CONRAD, C., ZEINDL-EBERHART, E., MOOSMANN, S., NELSON, P.J., BRUNS, C.J. and HUSS, R. (2008). Alkaline phosphatase, glutathione-S-transferase-P, and cofilin-1 distinguish multipotent mesenchymal stromal cell lines derived from the bone marrow versus peripheral blood. Stem Cells Dev 17: 23-27.
8. DEZAWA, M., ISHIKAWA, H., ITOKAZU, Y., YOSHIHARA, T., HOSHINO, M., TAKEDA, S., IDE, C. and NABESHIMA, Y. (2005). Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309: 314-317.
9. DEZAWA, M., KANNO, H., HOSHINO, M., CHO, H., MATSUMOTO, N., ITOKAZU, Y., TAJIMA, N., YAMADA, H., SAWADA, H., ISHIKAWA, H. et al. (2004). Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113: 1701-1710.
10. DOMINICI, M., LE BLANC, K., MUELLER, I., SLAPER-CORTENBACH, I., MARINI, F., KRAUSE, D., DEANS, R., KEATING, A., PROCKOP, D. and HORWITZ, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
11. DRAPER, J.S., PIGOTT, C., THOMSON, J.A. and ANDREWS, P.W. (2002). Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200: 249-258.
12. FRIEDENSTEIN, A.J., PIATETZKY, S., II and PETRAKOVA, K.V. (1966). Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16: 381-390.
13. FURUE, M., OKAMOTO, T., HAYASHI, Y., OKOCHI, H., FUJIMOTO, M., MYOISHI, Y., ABE, T., OHNUMA, K., SATO, G.H., ASASHIMA, M. et al. (2005). Leukemia inhibitory factor as an anti-apoptotic mitogen for pluripotent mouse embryonic stem cells in a serum-free medium without feeder cells. In vitro Cell Dev Biol Anim 41: 19-28.
14. FURUE, M.K., NA, J., JACKSON, J.P., OKAMOTO, T., JONES, M., BAKER, D., HATA, R., MOORE, H.D., SATO, J.D. and ANDREWS, P.W. (2008). Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci USA 105: 13409-13414.
15. FURUE, M.K., TATEYAMA, D., KINEHARA, M., J. NA, OKAMOTO, T. and SATO, J.D. (2010). Advantages and difficulties in culturing human pluripotent stem cells in growth factor-defined serum-free medium. In vitro Cell. Dev. Biol. Animal 46: 573-576.
16. HAYNESWORTH, S.E., BABER, M.A. and CAPLAN, A.I. (1992). Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13: 69-80.
17. HOFFMAN, L.M. and CARPENTER, M.K. (2005). Characterization and culture of human embryonic stem cells. Nat Biotechnol 23: 699-708.
18. ISHII, K., YOSHIDA, Y., AKECHI, Y., SAKABE, T., NISHIO, R., IKEDA, R., TERABAYASHI, K., MATSUMI, Y., GONDA, K., OKAMOTO, H. et al. (2008). Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta. Hepatology 48: 597-606.
19. KULTERER, B., FRIEDL, G., JANDROSITZ, A., SANCHEZ-CABO, F., PROKESCH, A., PAAR, C., SCHEIDELER, M., WINDHAGER, R., PREISEGGER, K.H. and TRAJANOSKI, Z. (2007). Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 8: 70.
20. KURODA, Y., KITADA, M., WAKAO, S., NISHIKAWA, K., TANIMURA, Y., MAKINOSHIMA, H., GODA, M., AKASHI, H., INUTSUKA, A., NIWA, A. et al. (2010). Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 107: 8639-8643.
21. LENNON DP, H.S., BRUDER SP, JAISWAL N, CAPLAN AI. (1996). Human and animal mesenchymal progenitor cells from bone marrow: identfication of serum for optimal selection and proliferation. In vitro Cell Dev Biol Anim 32: 602-611.
22. LI, W.G. and XU, X.X. (2005). The expression of N-cadherin, fibronectin during chondrogenic differentiation of MSC induced by TGF-beta(1). Chin J Traumatol 8: 349-351.
23. METS, T. and VERDONK, G. (1981). In vitro aging of human bone marrow derived stromal cells. Mech Ageing Dev 16: 81-89.
24. MORI, T., KIYONO, T., IMABAYASHI, H., TAKEDA, Y., TSUCHIYA, K., MIYOSHI, S., MAKINO, H., MATSUMOTO, K., SAITO, H., OGAWA, S. et al. (2005). Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol Cell Biol 25: 5183-5195.
25. NA, J., FURUE, M.K. and ANDREWS, P.W. (2010). Inhibition of ERK1/2 prevents neural and mesendodermal differentiation and promotes human embryonic stem cell self-renewal. Stem Cell Res 5: 157-169.
26. PANG, R., ZHANG, Y., PAN, X., GU, R., HOU, X., XIANG, P., LIU, Z., ZHU, X., HU, J., ZHAO, J. et al. (2010). Embryonic-like stem cell derived from adult bone marrow: immature morphology, cell surface markers, ultramicrostructure and differentiation into multinucleated fibers in vitro. Cell Mol Biol (Noisy-le-grand) 56 Suppl: OL1276-1285.
27. PITTENGER, M.F., MACKAY, A.M., BECK, S.C., JAISWAL, R.K., DOUGLAS, R., MOSCA, J.D., MOORMAN, M.A., SIMONETTI, D.W., CRAIG, S. and MARSHAK, D.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
28. POCHAMPALLY, R.R., SMITH, J.R., YLOSTALO, J. and PROCKOP, D.J. (2004). Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103: 1647-1652.
29. ROUBELAKIS, M.G., PAPPA, K.I., BITSIKA, V., ZAGOURA, D., VLAHOU, A., PAPADAKI, H.A., ANTSAKLIS, A. and ANAGNOU, N.P. (2007). Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16: 931-952.
30. SEKIYA, I., LARSON, B.L., SMITH, J.R., POCHAMPALLY, R., CUI, J.G. and PROCKOP, D.J. (2002). Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530-541.
31. SHEVINSKY, L.H., KNOWLES, B.B., DAMJANOV, I. and SOLTER, D. (1982). Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30: 697-705.
32. SHIMOMURA, T., YOSHIDA, Y., SAKABE, T., ISHII, K., GONDA, K., MURAI, R., TAKUBO, K., TSUCHIYA, H., HOSHIKAWA, Y., KURIMASA, A. et al. (2007). Hepatic differentiation of human bone marrow-derived UE7T-13 cells: Effects of cytokines and CCN family gene expression. Hepatol Res 37: 1068-1079.
33. TAKEUCHI, M., TAKEUCHI, K., KOHARA, A., SATOH, M., SHIODA, S., OZAWA, Y., OHTANI, A., MORITA, K., HIRANO, T., TERAI, M. et al. (2007). Chromosomal instability in human mesenchymal stem cells immortalized with human papilloma virus E6, E7, and hTERT genes. In vitro'Cell Dev Biol Anim 43: 129-138.
34. TSUTSUMI, S., SHIMAZU, A., MIYAZAKI, K., PAN, H., KOIKE, C., YOSHIDA, E., TAKAGISHI, K. and KATO, Y. (2001). Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288: 413-419.